Tuesday, June 29 2010, 3:00pm - 7:00pm
This joint QB3 and BayBio event will provide a rare opportunity for Northern California life sciences companies to tour core facilities at UCSF Mission Bay and to learn about the state-of-the-art support services and technologies they provide, as well as their availability to aid commercial scientific research and investigative teams. A distinguished panel of experts will examine the benefits of industry, academia and venture collaboration for improving translational research following the tours.
What: Mission Bay Open House and Panel Discussion When: June 29, 2010 UCSF Core Facilities Tours and Poster Sessions: 3:00pm - 5:00pm Panel Discussion: Mission Bay on a Mission: 5:00pm – 6:00pm Networking Reception: 6:00 – 7:00pm Where: UCSF Mission Bay 1700 4th St, Byers Hall, San Francisco, CA Directions Parking: Garage parking available $3/hr Attire: Business attire suggested Cost: Tours Only: $20 BayBio Members | $40 Non-Members Tours, Panel Discussion and Reception: $40 Members | $75 Non-Members Panel Discussion: Mission Bay on a Mission A panel of remarkable biotech leaders will explore how unique collaboration between university, venture capital and corporations can improve translational medicine and accelerate bringing improved products and services to society. The panel will explore how these partners in life science product development can be matched more efficiently, and how product development costs can be lowered and R&D process can be further de-risked. Panel Participants: Brook Byers - Partner, Kleiner Perkins Caufield & Byers Sue Desmond-Hellman - Chancellor, UCSF Regis Kelly - Executive Director, QB3 Gail Maderis - President and CEO, BayBio Uwe Schoenbeck - CSO, BioTherapeutics External R&D Innovation, Pfizer, Inc. For More Information and Registration, Click Here Location1700 4th St, Byers Hall, San Francisco, CA |
